文献速递神经肿瘤脑血管病外科神经重症

颅脑神经外科术后不良事件与捆绑费用:LACE指数验证及LACE-Cranial模型开发

Adverse Events and Bundled Costs after Cranial Neurosurgical Procedures: Validation of the LACE Index Across 40,431 Admissions and Development of the LACE-Cranial Index.
PubMed 文献 · World Neurosurg · 2020-10-28

基于OptumClinformatics数据库纳入40,431例颅脑神经外科住院,验证LACE指数对出院后30天不良事件的预测能力,并开发增强模型LACE-Cranial。原始LACE预测再入院能力普遍较差,但对功能性/疼痛手术30天死亡率预测极佳(AUC 0.957)。LACE-Cranial将各术式30天死亡率AUC提升至0.904–0.98,并改善再入院预测。

要点

  • 原始LACE对颅脑术后30天再入院预测普遍较差,最优为颅底(AUC 0.636)和肿瘤(AUC 0.63)。
  • LACE-Cranial模型对各术式30天死亡率预测AUC达0.904–0.98,肿瘤和颅底90天再入院AUC为0.718和0.717。
  • 除功能性/疼痛手术外,高风险LACE评分与更高的出院后捆绑支付费用相关。

核心结论

  • 未经调整的LACE指数在颅脑神经外科中分类性能不一致,增强的LACE-Cranial模型对短期出院后死亡预测优秀,并显著改善短期再入院预测。

研究设计与样本

  • 利用OptumClinformatics数据库识别2004–2017年颅脑神经外科住院,共纳入40,431例。
  • 手术分组为创伤/血肿/颅内压、开放血管、功能/疼痛、颅底、肿瘤或血管内治疗。
  • 不良事件定义为出院后死亡或再入院,LACE-Cranial采用逻辑回归框架纳入扩展特征集开发。

主要发现

  • 30天再入院预测最优为颅底(AUC 0.636)和肿瘤(AUC 0.63),但总体较差。
  • 30天死亡率预测最优为功能/疼痛(AUC 0.957),最差为创伤/血肿/颅内压(AUC 0.613)。
  • 除功能/疼痛外,高风险LACE评分与更高的出院后捆绑支付费用相关。
  • LACE-Cranial对各术式30天死亡率AUC为0.904–0.98,肿瘤和颅底90天再入院AUC分别为0.718和0.717。

临床怎么用

  • LACE-Cranial可用于颅脑神经外科术后短期死亡和再入院的个体化风险分层。
  • 原始LACE指数不宜直接用于颅脑术后再入院预测,需结合术式特异性模型。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Anticipating postdischarge complications after neurosurgery remains difficult. The LACE index, based on 4 hospitalization descriptors, stratifies patients by risk of 30-day postdischarge adverse events but has not been validated in a procedure-specific manner in neurosurgery. Our study sought to explore the usefulness of the LACE index in a population undergoing cranial neurosurgery and to develop an enhanced model, LACE-Cranial. METHODS: The OptumClinformatics Database was used to identify cranial neurosurgery admissions (2004-2017). Procedures were grouped as trauma/hematoma/intracranial pressure, open vascular, functional/pain, skull base, tumor, or endovascular. Adverse events were defined as postdischarge death/readmission. LACE-Cranial was developed using a logistic regression framework incorporating an expanded feature set in addition to the original LACE components. RESULTS: A total of 40,431 admissions were included. Predictions of 30-day readmissions was best for skull base (area under the curve [AUC], 0.636) and tumor (AUC, 0.63) admissions but was generally poor. Predictive ability of 30-day mortality was best for functional/pain admissions (AUC, 0.957) and poorest for trauma/hematoma/intracranial pressure admissions (AUC, 0.613). Across procedure types except for functional/pain, a high-risk LACE score was associated with higher postdischarge bundled payment costs. Incorporating features identified to contribute independent predictive value, the LACE-Cranial model achieved procedure-specific 30-day mortality AUCs ranging from 0.904 to 0.98. Prediction of 30-day and 90-day readmissions was also improved, with tumor and skull base cases achieving 90-day readmission AUCs of 0.718 and 0.717, respectively. CONCLUSIONS: Although the unmodified LACE index shows inconsistent classification performance, the enhanced LACE-Cranial model offers excellent prediction of short-term postdischarge mortality across procedure groups and significantly improved anticipation of short-term postdischarge readmissions.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Jin MC, Wu A, Medress ZA, et al. Adverse Events and Bundled Costs after Cranial Neurosurgical Procedures: Validation of the LACE Index Across 40,431 Admissions and Development of the LACE-Cranial Index. World Neurosurg. 2020. PMID: 33127572. doi:10.1016/j.wneu.2020.10.103

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。